Literature DB >> 25270874

What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Charlotte Whitmore1, Jennifer Morgan.   

Abstract

There are over 30 mouse models with mutations or inactivations in the dystrophin-associated protein complex. This complex is thought to play a crucial role in the functioning of muscle, as both a shock absorber and signalling centre, although its role in the pathogenesis of muscular dystrophy is not fully understood. The first mouse model of muscular dystrophy to be identified with a mutation in a component of the dystrophin-associated complex (dystrophin) was the mdx mouse in 1984. Here, we evaluate the key characteristics of the mdx in comparison with other mouse mutants with inactivations in DAPC components, along with key modifiers of the disease phenotype. By discussing the differences between the individual phenotypes, we show that the functioning of the DAPC and consequently its role in the pathogenesis is more complicated than perhaps currently appreciated.
© 2014 The Authors. International Journal of Experimental Pathology © 2014 International Journal of Experimental Pathology.

Entities:  

Keywords:  dystroglycan; dystrophin; mdx; mouse models; muscular dystrophy

Mesh:

Substances:

Year:  2014        PMID: 25270874      PMCID: PMC4285463          DOI: 10.1111/iep.12095

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  136 in total

1.  Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.

Authors:  A M Connolly; R M Keeling; S Mehta; A Pestronk; J R Sanes
Journal:  Neuromuscul Disord       Date:  2001-11       Impact factor: 4.296

2.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.

Authors:  P W Hamer; J M McGeachie; M J Davies; M D Grounds
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

3.  mdx(⁵cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice.

Authors:  Nicholas Beastrom; Haiyan Lu; Allison Macke; Benjamin D Canan; Eric K Johnson; Christopher M Penton; Brian K Kaspar; Louise R Rodino-Klapac; Lan Zhou; Paul M L Janssen; Federica Montanaro
Journal:  Am J Pathol       Date:  2011-09-03       Impact factor: 4.307

4.  Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle.

Authors:  Michael J Allikian; Andrew A Hack; Stephanie Mewborn; Ulrike Mayer; Elizabeth M McNally
Journal:  J Cell Sci       Date:  2004-07-13       Impact factor: 5.285

5.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

Authors:  G A Cox; S F Phelps; V M Chapman; J S Chamberlain
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

6.  T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.

Authors:  A Farini; M Meregalli; M Belicchi; M Battistelli; D Parolini; G D'Antona; M Gavina; L Ottoboni; G Constantin; R Bottinelli; Y Torrente
Journal:  J Pathol       Date:  2007-10       Impact factor: 7.996

Review 7.  PCR analysis of muscular dystrophy in mdx mice.

Authors:  J S Chamberlain; S F Phelps; G A Cox; A J Maichele; A D Greenwood
Journal:  Mol Cell Biol Hum Dis Ser       Date:  1993

8.  Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.

Authors:  Q L Lu; G E Morris; S D Wilton; T Ly; O V Artem'yeva; P Strong; T A Partridge
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

9.  The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.

Authors:  J D Porter; J A Rafael; R J Ragusa; J K Brueckner; J I Trickett; K E Davies
Journal:  J Cell Sci       Date:  1998-07       Impact factor: 5.285

10.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Authors:  F Duclos; V Straub; S A Moore; D P Venzke; R F Hrstka; R H Crosbie; M Durbeej; C S Lebakken; A J Ettinger; J van der Meulen; K H Holt; L E Lim; J R Sanes; B L Davidson; J A Faulkner; R Williamson; K P Campbell
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  11 in total

Review 1.  Current Progress in Therapeutic Gene Editing for Monogenic Diseases.

Authors:  Versha Prakash; Marc Moore; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

2.  Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice.

Authors:  D Randazzo; B Blaauw; C Paolini; E Pierantozzi; S Spinozzi; S Lange; J Chen; F Protasi; C Reggiani; V Sorrentino
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-26       Impact factor: 4.249

Review 3.  Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.

Authors:  Rylie M Hightower; Matthew S Alexander
Journal:  Muscle Nerve       Date:  2017-09-22       Impact factor: 3.217

Review 4.  Overview of the Muscle Cytoskeleton.

Authors:  Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

5.  The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells.

Authors:  Jinhong Meng; Maximilien Bencze; Rowan Asfahani; Francesco Muntoni; Jennifer E Morgan
Journal:  Skelet Muscle       Date:  2015-04-28       Impact factor: 4.912

6.  Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F.

Authors:  S Pasteuning-Vuhman; K Putker; C L Tanganyika-de Winter; J W Boertje-van der Meulen; L van Vliet; M Overzier; J J Plomp; A Aartsma-Rus; M van Putten
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 7.  Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy.

Authors:  Quynh Nguyen; Toshifumi Yokota
Journal:  J Pers Med       Date:  2017-10-16

Review 8.  Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.

Authors:  Merryl Rodrigues; Yusuke Echigoya; So-Ichiro Fukada; Toshifumi Yokota
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 9.  Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies.

Authors:  Ahlke Heydemann
Journal:  Nutrients       Date:  2018-06-20       Impact factor: 5.717

Review 10.  Skeletal muscle in health and disease.

Authors:  Jennifer Morgan; Terence Partridge
Journal:  Dis Model Mech       Date:  2020-02-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.